News Article,Video
Maple Grove Medical Device Company Shares How They are Surviving During COVID-19
October 5, 2020
CCX Media visited Francis Medical on September 30, 2020, to interview President and CEO Mike Kujak, and get an inside look at how we’re thriving and moving forward during the COVID-19 pandemic, including a $4M investment from world-renown urology company, Coloplast. (2 1/2 min video)
Recent Posts
University of Chicago Urologist Performs First Commercial Vanquish® Water Vapor Ablation Procedures in the State
Minneapolis [May 06, 2026] – Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Naveen Kella, MD, of The Urology Place has successfully completed the first commercial procedures in San Antonio, Texas, using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue. Dr. Kella, who was also a clinical investigator in the VAPOR 2 pivotal study, performed the procedures on patients diagnosed with localized prostate cancer at Huebner Ambulatory Surgery Center.
Francis Medical Announces Further Expansion of Commercial Vanquish® Procedures to Ablate Prostate Tissue
Minneapolis [May 06, 2026] – Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Naveen Kella, MD, of The Urology Place has successfully completed the first commercial procedures in San Antonio, Texas, using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue. Dr. Kella, who was also a clinical investigator in the VAPOR 2 pivotal study, performed the procedures on patients diagnosed with localized prostate cancer at Huebner Ambulatory Surgery Center.
Francis Medical Announces First Commercial Vanquish® Procedure to Ablate Prostate Tissue in the Midwest
Minneapolis [April 21, 2026] – Francis Medical, Inc., a privately held medical device company based out of Maple Grove, MN, today announced that Aaron Milbank, MD. of Minnesota Urology has successfully completed the first commercial procedure in the Midwest using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue.
Federal law (USA) restricts this device to sale by or on the order of a physician.
Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.